Covid-19 registry for atopic dermatitis patients (SECURE-AD)

Have any of your patients with atopic dermatitis developed COVID-19?

Please report your cases to SECURE-AD (https://www.covidderm.org/) via a simple anonymised case report form. 

SECURE-AD is a global registry for healthcare professionals to report outcomes of COVID-19 in individuals with atopic dermatitis. 

Entering your cases is quick and can be done during a virtual consultation. All data is de-identified.

The information you provide will rapidly improve our understanding of how factors such as systemic immunomodulatory therapies, comorbidities and disease activity affect outcomes of COVID-19 in atopic dermatitis. Regular open-access summaries of reported cases will be provided online. 

SECURE-AD is closely aligned with other Covid-19 skin disease registries, such as SECURE-Alopecia (https://securealopecia.covidderm.org/login/?next=/insight/) and PsoProtect (www.psoprotect.org) and comparative analyses are planned.

We look forward to working with you all on this important international effort. 

Alan Irvine, Phyllis Spuls, and Carsten Flohr (on behalf of the SECURE-AD Steering Group)

Alain Taieb and Andreas Wollenberg (on behalf of the SECURE-AD Scientific Advisory Committee)

Written by

dirkjanhijnen

Dermatologist, ErasmusMC Rotterdam, The Netherlands